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 Despite these shortcomings, the novelty 
of this paper can be summarized as fol-
lows: (1) Th e authors provide evidence 
that the 129x1 / SvJ mouse is susceptible to 
adriamycin-mediated nephropathy and 
suggest that this model can be used to 
study the temporal changes that occur 
in focal segmental glomerulosclerosis. 
(2) Th is is the fi rst demonstration that 
p110   , an isoform of PI3  K that is 
expressed by lymphatic cells, is upregu-
lated in injured podocytes both  in vivo 
and  in vitro . (3) Th is PI3  K isoform con-
tributes to podocyte injury by downregu-
lating nephrin expression and altering the 
cytoskeleton. (4) Selective blockade 
of p110  ameliorates early proteinuria 
before upregulation of TGF- β is evident. 
(5) Th e authors demonstrate a selective 
function for TGF- β versus p110  in 
 driving  adriamycin-mediated injury. 
Th us, this study shows that proteinuria 
and renal fibrogenesis involve distinct 
cell types and signaling mechanisms 
( Figure 1 ), and suggests that inhibiting 
p110  might have a better overall benefi -
cial effect than traditional anti-TGF- β 
therapy early in the disease course. 
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 Role changes of   -catenin in 
kidney injury and repair 
 Jianping  Peng 1 , 2 and  Zheng  Dong 1 , 3 
 Using conditional knockout models, Zhou  et al. firmly establish a 
renoprotective role of   -catenin in acute kidney injury. Although 
  -catenin is protective at the injury phase, whether it helps kidney 
repair remains in question. In a renal cell scratch model,   -catenin 
suppresses wound healing. Moreover, continuous activation of   -
catenin may lead to renal fibrosis. Further investigation should elucidate 
the distinct roles played by   -catenin and related signaling in kidney 
injury, repair, and fibrosis. 
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  -catenin and related signaling play an 
active role in nephron formation in the 
early stage of kidney development; how-
ever, it is largely silent in adult kidneys. 
Nonetheless, this signaling pathway is 
activated in kidney tubules, podocytes, 
and interstitial cells under numerous dis-
ease conditions, including diabetic neph-
ropathy, cystic kidney disease, and acute 
kidney injury (AKI), just to name a few. 
Despite these observations, the patho-
logical role played by   -catenin in kidney 
diseases is poorly understood. Using a 
conditional knockout mouse model, Zhou 
and colleagues 1 (this issue) have now 
demonstrated compelling evidence for a 
renoprotective role of   -catenin in AKI. 
 In this study,   -catenin was fi rst shown 
to be markedly induced in kidney tubules 
in a nephrotoxic AKI model of folic acid 
treatment. 1 To demonstrate the patho-
logical role of   -catenin, a conditional 
knockout model was then established, in 
which   -catenin was ablated specifi cally 
from kidney tubules by the crossing of 
Ksp-Cre mice with   -catenin-fl oxed ani-
mals. The mice from this conditional 
knockout model showed significantly 
more severe AKI aft er folic acid treatment. 
Compared with wild-type, the knockout 
mice had a higher morta-lity rate, severer 
tissue damage, more renal apoptosis, and 
heightened renal failure. Consistently, 
these animals were more sensitive to AKI 
induced by renal ischemia – reperfusion. 
Mechanistically,   -catenin knockout 
kidney tissues showed an upregulation of 
proapoptotic genes, such as p53 and Bax, 
and a decrease in survival factors, includ-
ing survivin and phosphorylated Akt. 
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 In vitro , activation of   -catenin protected 
cultured tubular cells from apoptosis; this 
was accompanied by induction of Akt and 
survivin and suppression of p53 and Bax. 
Collectively, these  in vitro and  in vivo 
results demonstrate a critical, renoprotec-
tive role of   -catenin in AKI. 
 A pro-survival or protective role of 
  -catenin in kidney tubular cells was sug-
gested by Borkan and colleagues in previ-
ous work. 2 Specifi cally, it was shown that 
the expression of active   -catenin signifi -
cantly decreased apoptosis and improved 
cell survival after ATP-depletion-
induced metabolic stress in kidney tubular 
cells, whereas blockade of   -catenin with 
dominant-negative mutants enhanced 
cell death. Interestingly, in this study the 
protective action of   -catenin was linked 
to the activation of Akt and Akt-mediated 
phosphorylation and inactivation of 
Bax, a pro-death Bcl-2-family protein. Th e 
current study by Zhou  et al. has extended 
the key  in vitro observations to  in vivo 
situations, demonstrating convincing 
evidence for a renoprotective role of 
  -catenin in AKI. 1 
 As a major upstream regulator of 
  -catenin, glycogen synthase kinase-3  
(GSK3  ) has also been implicated in 
AKI. 3 GSK3  was shown to be activated 
during ATP depletion in kidney tubular 
cells. While suppression of GSK3  pro-
moted tubular-cell survival, expression of 
constitutively active GSK3  led to Bax 
activation and cell death. Importantly, in 
rats, pharmacologic inhibitors of GSK3  
ameliorated kidney tubular-cell injury and 
protected against ischemic AKI. Despite 
these fi ndings, the study did not deter-
mine whether the injurious action of 
GSK3  was through the regulation or sup-
pression of   -catenin; instead, it was 
suggested that GSK3  may directly phos-
phorylate Bax, resulting in its activation, 
mitochondrial permeabilization, and 
apoptosis. 3 Zhou  et al. have now demon-
strated   -catenin induction in kidney tis-
sues at 48 hours aft er ischemia or folic 
acid-induced AKI. How is   -catenin 
induced under these conditions? An obvi-
ous answer may lie in GSK3  : inactivation 
or inhibition of GSK3  can suppress   -
catenin degradation and cause   -catenin 
stabilization in the cytoplasm and trans-
location to the nucleus. Further research 
should test this possibility and gain 
insights into the mechanism of   -catenin 
induction during AKI. 
  -Catenin is a  ‘ dual-function ’ protein in 
cells, and its function is largely determined 
by its subcellular localization. In the 
plasma membrane,   -catenin is a compo-
nent of the E-cadherin adhesion complex 
that stabilizes cell adherens junctions to 
maintain epithelial integrity. In the 
nucleus, however,   -catenin acts as a key 
regulator of gene expression via binding 
to transcription factors such as T-cell fac-
tor and lymphoid enhancer-binding fac-
tor. 4 Th e canonical pathway regulating 
  -catenin involves GSK3  / Wnt signaling. 
In unstimulated cells,    -catenin is 
degraded via the proteosomal pathway 
aft er GSK3  -mediated phosphorylation 
in a multiprotein complex. Th e activation 
of Wnt signaling leads to GSK3  phos-
phorylation and inactivation, resulting in 
the stabilization and accumulation of 
  -catenin, which may translocate into 
the nucleus to induce gene expression. 4 
 Following injury, kidney tissues are 
highly capable of regeneration or repair. 
Especially, the surviving cells in renal 
tubules can rapidly dedifferentiate and 
migrate to cover the wound, and then pro-
liferate and rediff erentiate to restore the 
structure and function of the tubule. 5 
Although a renoprotective role of   -
catenin in AKI has now been fi rmly estab-
lished, 1,3 its involvement in kidney repair 
remains poorly understood. Th e induction 
of   -catenin at 48 hours aft er injury 1 sug-
gests that it may also participate in kidney 
repair. In this regard, our recent study 
examined the role of   -catenin in wound 
healing using a cell scratch model. 6 A rapid 
  -catenin induction was detected in the 
cells at the wound edges. Notably, in this 
model overexpression of   -catenin as well 
as inhibition of GSK3  blocked wound 
healing, suggesting that   -catenin plays an 
inhibitory role in wound healing in kidney 
tubular cells. 6 Th us,   -catenin may have a 
dual role in AKI: protecting against tubu-
lar-cell injury initially, yet suppressing 
kidney repair during the recovery phase 
( Figure 1 ). If this is proven true, inhibition 
of GSK3  and activation of   -catenin may 
off er a useful therapeutic strategy before 
and during kidney injury; however, it 
would be important to suppress   -catenin 
during subsequent kidney repair. Obvi-
ously, such a conclusion should be sub-
stantiated by a thorough investigation of 
the role of   -catenin in kidney repair using 
 in vivo models. 
 Finally, a notable feature of kidney 
repair following AKI is renal fibrosis, 
which is considered the springboard 
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 Figure 1  |  Role of   -catenin in kidney injury and repair. During the early injury phase of acute 
kidney injury (AKI), GSK3  is activated, which may phosphorylate and activate Bax to induce 
apoptosis in renal tubular cells. During the recovery phase of AKI,   -catenin is induced, which 
promotes tubular-cell survival by blocking the cell-killing molecules (for example, p53, Bax) 
and activating the pro-survival factors (for example, Akt, survivin). However,   -catenin may also 
suppress wound healing in kidney tissues by inhibiting cell migration, and promote abnormal 
kidney repair by inducing fibrosis. 
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for the progression from AKI to chronic 
kidney disease. 7 Interestingly,   -catenin 
activation was frequently detected in 
fi brotic kidney tissues, 8 and inhibition of 
  -catenin signaling reduced fi brosis in the 
model of obstructive nephropathy. 9 Does 
  -catenin also have a role in renal fi brosis? 
In cultured renal tubular cells,   -catenin 
overexpression suppressed E-cadherin 
expression and induced fibronectin, a 
profi brotic factor. Remarkably, ICG-001, 
a pharmacologic inhibitor of   -catenin, 
was able to abolish transforming growth 
factor-  1-induced expression of fi brotic 
genes including fi bronectin, collagen I, 
and   -smooth muscle actin.  In vivo , ICG-
001 also effectively attenuated fibrotic 
lesions in obstructive nephropathy. 10 
Pending further experimental evidence, 
we speculate that   -catenin may also con-
tribute to the development of renal fi bro-
sis aft er AKI and initial repair ( Figure 1 ). 
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 Benefits of short daily home 
hemodialysis in the FREEDOM 
Study: is it about person, 
place, time, or treatment ? 
 Khaled  Abdel-Kader 1 and  Mark L.  Unruh 1 
 Many end-stage renal disease patients receive thrice-weekly 
hemodialysis (HD) and report impairments in health-related quality of 
life (HRQOL). Recent studies indicate that short daily HD may improve 
HRQOL. High-quality studies exploring the burdens and costs to 
patients, caregivers, and society are necessary before widespread 
adoption can be advocated. Further research exploring the mechanisms 
by which these benefits are realized is also important, as many patients 
are likely to opt out of short daily HD. 
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 Despite recent trends of increased use of 
home hemodialysis (HD), the overwhelm-
ing majority of maintenance HD patients 
in the United States receive thrice-weekly 
in-center HD. Unfortunately, the mortal-
ity and health-related quality of life 
(HRQOL) of these patients remain poor. 1 
Much research has focused on modifi ca-
tions to the dialysis procedure in hopes of 
improving these outcomes. Th e Hemo-
dialysis Study showed that improvements 
in middle-molecule clearance or  Kt / V , 
while preserving the thrice-weekly sched-
ule, did not substantively improve mortal-
ity or HRQOL. 2,3 In contrast, the recently 
published Frequent Hemodialysis 
Network (FHN) daily trial showed that 
short daily HD improved the co-primary 
outcomes (mortality or left  ventricular 
mass, and mortality or physical-health 
composite score of the RAND 36-item 
health survey) as well as predialysis phos-
phorus and systolic blood pressure. 4 
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 Given the recruitment and logistical 
challenges of the FHN studies, larger ran-
domized controlled trials are unlikely to 
be conducted in the near future. Hence, 
further evidence regarding the potential 
benefi ts, risks, and burdens of short daily 
HD will probably come from large, high-
quality, observational studies. Th e Follow-
ing Rehabilitation, Economics and 
Everyday-Dialysis Outcome Measure-
ments (FREEDOM) Study is an ongoing 
prospective multicenter observational 
study examining the eff ects of at-home 
short daily HD (six times per week) with 
the NxStage System (NxStage Medical) on 
hospitalizations, medical costs, and 
HRQOL. 5 Th e study seeks to enroll 500 
end-stage renal disease (ESRD) patients at 
least 18 years of age who are deemed can-
didates for short daily HD and have Medi-
care as their primary insurer. 
 In this issue of  Kidney International , the 
study investigators report their prespeci-
fied interim analysis on changes in 
HRQOL assessed by the SF-36 health sur-
vey at months 4 and 12 following initia-
tion of at-home short daily HD. 5 Of the 
291 enrolled participants, 154 completed 
assessments at 12 months. After using 
random-eff ects models to address missing 
